Abstract:Host cells have evolved an intricate regulatory network to fine tune the type-I interferon responses. However, the full picture of this regulatory network remains to be depicted. In this study, we found that knock out of zinc-finger CCHC-type containing protein 8 (ZCCHC8) impairs the replication of influenza A virus (IAV), Sendai virus (Sev), Japanese encephalitis virus (JEV), and vesicular stomatitis virus (VSV). Further investigation unveiled that ZCCHC8 suppresses the type-I interferon responses by targeting the interferon regulatory factor 3 (IRF3) signaling pathway. Mechanistically, ZCCHC8 associates with phosphorylated IRF3 and disrupts the interaction of IRF3 with the co-activator CREB-binding protein (CBP). Additionally, the direct binding of ZCCHC8 with the IFN-stimulated response element (ISRE) impairs the ISRE-binding of IRF3. Our study contributes to the comprehensive understanding for the negative regulatory network of the type-I interferon responses and provides valuable insights for the control of multiple viruses from a host-centric perspective.IMPORTANCEThe innate immune responses serve as the initial line of defense against invading pathogens and harmful substances. Negative regulation of the innate immune responses plays an essential role in avoiding auto-immune diseases and over-activated immune responses. Hence, the comprehensive understanding of the negative regulation network for innate immune responses could provide novel therapeutic insights for the control of viral infections and immune dysfunction. In this study, we report that ZCCHC8 negatively regulates the type-I interferon responses. We illustrate that ZCCHC8 impedes the IRF3-CBP association by interacting with phosphorylated IRF3 and competes with IRF3 for binding to ISRE. Our study demonstrates the role of ZCCHC8 in the replication of multiple RNA viruses and contributes to a deeper understanding of the negative regulation system for the type-I interferon responses.

JMJD6 negatively regulates cytosolic RNA induced antiviral signaling by recruiting RNF5 to promote activated IRF3 K48 ubiquitination

Bcl6 Sets a Threshold for Antiviral Signaling by Restraining IRF7 Transcriptional Program

FBXO6 Regulates the Antiviral Immune Responses Via Mediating Alveolar Macrophages Survival

Mst1 shuts off cytosolic antiviral defense through IRF3 phosphorylation.

Negative Regulation of RNF90 on RNA Virus-Triggered Antiviral Immune Responses Targeting MAVS

Zinc-finger CCHC-type containing protein 8 promotes RNA virus replication by suppressing the type-I interferon responses

E3 Ligase FBXW7 is Critical for RIG-I Stabilization During Antiviral Responses

Enhancer of zeste homolog 2 is a negative regulator of mitochondria-mediated innate immune responses.

N6-methyladenosine RNA modification suppresses antiviral innate sensing pathways via reshaping double-stranded RNA

ZNFX1 antisense RNA1 promotes antiviral innate immune responses via modulating ZNFX1 function

m6A modification associated with YTHDF1 is involved in Japanese encephalitis virus infection

N 6-Methyladenosine RNA Modification Suppresses Antiviral Innate Sensing Pathways Via Reshaping Double-Stranded RNA

MicroRNA-146a feedback inhibits RIG-I-dependent Type I IFN production in macrophages by targeting TRAF6, IRAK1, and IRAK2.

The RNA helicase DDX5 promotes viral infection via regulating N6-methyladenosine levels on the DHX58 and NFκB transcripts to dampen antiviral innate immunity

Myeloid neddylation targets IRF7 and promotes host innate immunity against RNA viruses

MST4 negatively regulates type I interferons production via targeting MAVS-mediated pathway

E3 ligase ASB3 downregulates antiviral innate immunity by targeting MAVS for ubiquitin-proteasomal degradation

CD97 Negatively Regulates the Innate Immune Response Against RNA Viruses by Promoting RNF125-mediated RIG-I Degradation.

RNF90 negatively regulates cellular antiviral responses by targeting MITA for degradation

BAG6 negatively regulates the RLR signaling pathway by targeting VISA/MAVS

Mitochondria-localised ZNFX1 functions as a dsRNA sensor to initiate antiviral responses through MAVS